SME Rating Agency of India is a ratings and research agency exclusively set up for micro, small and medium enterprises in India. It provides ratings which enable MSME, SMEs, to raise bank loans at competitive rates of interest. SMERA now operates as a separate division of Acuité Ratings & Research Limited. Read More
India Ratings and Research (Ind-Ra) has said that Indian active pharmaceutical ingredient (API) companies will benefit from improving demand outlook in the United States. ...
The overall residential demand is expected to decline by over 25 per cent year-on-year in the current financial year FY21 due to ongoing COVID-19 pandemic after registering a fall of 5 per cent in FY20, according to India Ratings and Research (Ind-Ra ...
Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said on Tues ...
The impact of COVID-19 and associated policy response is likely to result in an additional Rs 1.67 lakh crore of debt from the top 500 debt-heavy private sector borrowers turning delinquent between FY21 and FY22, India Ratings and Research (Ind-Ra) s ...
Steel prices could fall further in coming weeks as domestic production will gradually increase with the easing of lockdown restrictions along with no corresponding increase in demand, according to India Ratings and Research (Ind-Ra). ...
India Ratings and Research (Ind-Ra) expects the gross state domestic product (GSDP) of all states in India to contract during the current financial year in the range of 1.4 to 14.3 per cent. ...
The government's announcement of enhancing gross borrowings to Rs 12 lakh crore from the budgeted Rs 7.8 lakh crore in FY21 will largely take care of the revenue shortfall, leaving little space for fiscal stimulus, unless the Centre sharply cuts the ...
